Skip to main content


Insights from 50 nephrology and healthcare experts across the US and Europe reveal that the future of CKD management will be driven by biomarker-based diagnostics, AI-powered analytics, precision medicine, and multidisciplinary care models. The study provides valuable perspectives for healthcare organizations, pharma companies, and digital health innovators.